TB control: India has been skipping these 6 of WHO's 16 key
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
As per a report by Médecins Sans Frontières (MSF) and Stop TB Partnership, India does not implement six out of the 16 key World Health Organisation (WHO)- recommended tuberculosis (TB) control policies in diagnosis, patient care and treatment while four other national are not being fully implemented.

- While WHO recommends Xpert MTB/RIF the initial test for TB in adults and children, India still follows Sputum smear microscopy as its inexpensive and easy to conduct

- Two of the strongest, first-line TB drugs are rifampicin and isoniazid. Patients who are resistant to the first usually do not respond to the second drug either. But in India, most rifampicin-resistant patients are not put through the first-line drug susceptibility test (DST) that could diagnose isoniazid resistance as well.

- India’s national TB policy does not reflect the nine-month WHO-recommended MDR TB regimen and continues the 24-month treatment but this might change by the end of 2017

- Even though HIV positive patients with latent TB are 26 times more likely to get active TB, India also does not use TB LAM to diagnose TB in persons living with HIV/AIDS

- WHO had recommended a fixed dosed combination of drugs for children in 2012 yet India doesn’t implement paediatric fixed drug combinations as the standard of care in all parts of the country.

-India has still Country is not enrolled in WHO Collaborative Registration Procedure

http://bit.ly/2uI3nCU
Dr. M●●●l T●●●●●●i and 48 others like this13 shares
Like
Comment
Share